Funding opportunity announcement: Tennessee Center For AIDS Research Developmental Core Awards
Letter of Intent Deadline: July 7
Application Deadline: Sept. 7
The Tennessee Center For AIDS Research (CFAR) is requesting applications for CFAR Developmental Core Awards. These awards are intended to support studies for short periods of time (~1 year) to develop preliminary data for highly competitive extramural research applications. Selected aspects of the FOA are provided below. Please refer to the full eight-page FOA document for detailed instructions and additional important information.
The highest priority of this program is to support:
• New investigators who do not have existing independent (e.g., R01) HIV research funding from the NIH. Recipients of mentored training grants (e.g. K awards) are welcome to apply. For the NIH definition of New Investigator see http://grants.nih.gov/grants/new_investigators/#definition.
This program may also support:
• Established investigators who are new to HIV research and have not previously received independent research awards such as an R01 in HIV/AIDS.
• Feasibility studies.
• Emerging research opportunities.
• HIV research activities of newly recruited faculty.
Applications are encouraged from any research discipline (clinical, translational, community, basic science, epidemiology, etc.). The CFAR will assure that early-stage investigators establish and maintain mentoring with established investigators so that they may acquire skills necessary for a career in HIV research.
All potential applicants should contact the Tennessee CFAR early in the proposal planning process, for guidance on making the application most responsive to this FOA. This will include how to best leverage cost sharing with VICTR Pilot Awards, available CFAR Core services, and how to connect with the Biostatistics and BioInformatics Core (BBIC), Community Engaged Research investigator and/or community stakeholders. For further information and questions, please contact Gina Perez, Ph.D. (email@example.com).
Note: Studies involving new drugs, treatments or devices cannot be funded through the CFAR. These studies must go through the NIH R34 process. Others may require additional NIH review. Please contact Perez if you have questions about this.